Cargando…
A novel antitumor dithiocarbamate compound inhibits the EGFR/AKT signaling pathway and induces apoptosis in esophageal cancer cells
Dithiocarbamate has been reported to possess a potent antitumor efficacy against several types of cancer, such as ovarian cancer, breast cancer and hepatocellular carcinoma; however, only a few studies have investigated its inhibitory effect on esophageal cancer. Dipyridylhydrazone dithiocarbamate (...
Autores principales: | Yang, Yun, Tian, Ziyin, Zhao, Xinghua, Li, Ya, Duan, Shuyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285826/ https://www.ncbi.nlm.nih.gov/pubmed/32566015 http://dx.doi.org/10.3892/ol.2020.11638 |
Ejemplares similares
-
EGFR-Targeted Immunotoxin Exerts Antitumor Effects on Esophageal Cancers by Increasing ROS Accumulation and Inducing Apoptosis via Inhibition of the Nrf2-Keap1 Pathway
por: Yang, Yun, et al.
Publicado: (2018) -
Electrochemical Studies of Dithiocarbamates and Related Compounds
por: Gomiscek, S., et al.
Publicado: (1988) -
Therapeutic potential of dithiocarbamate supported gold compounds
por: Adokoh, Christian K.
Publicado: (2020) -
Dithiocarbamate as a Valuable Scaffold for the Inhibition of Metallo-β-Lactmases
por: Ge, Ying, et al.
Publicado: (2019) -
Nrf2 Inhibitor, Brusatol in Combination with Trastuzumab Exerts Synergistic Antitumor Activity in HER2-Positive Cancers by Inhibiting Nrf2/HO-1 and HER2-AKT/ERK1/2 Pathways
por: Yang, Yun, et al.
Publicado: (2020)